---
title: Ethical implications of genetic modifications
videoId: 0OXaanDHENI
---

From: [[⁨cleoabram⁩]] <br/> 
Gene editing technology, particularly CRISPR-Cas9, has given humanity the unprecedented ability to modify its own genes, raising profound ethical questions about its application <a class="yt-timestamp" data-t="00:00:00">[00:00:00]</a>. This power allows for the potential to cure diseases, prevent others, enhance bodily functions, and even bestow new abilities upon future generations, effectively placing evolution in human hands <a class="yt-timestamp" data-t="00:00:07">[00:00:07]</a>. This is not a futuristic concept; CRISPR is already being used in medicine, agriculture, and animal modification <a class="yt-timestamp" data-t="00:00:21">[00:00:21]</a>. Deciding how to wield this "new superpower" represents one of the greatest challenges and opportunities to reduce human suffering <a class="yt-timestamp" data-t="00:00:41">[00:00:41]</a>.

## CRISPR-Cas9: A Foundational Breakthrough

For over a century, scientists have understood that specific molecules within cells carry genetic information in a four-part code, which cells use as a blueprint for making proteins that govern human traits, from appearance to disease susceptibility <a class="yt-timestamp" data-t="00:03:00">[00:03:00]</a>. However, for most of that time, the genetic code could only be read, not changed <a class="yt-timestamp" data-t="00:03:23">[00:03:23]</a>.

CRISPR-Cas9, discovered by Jennifer Doudna (who won a Nobel Prize for her work), marked a significant leap from earlier gene manipulation tools like Zinc-finger nucleases and TALEN proteins <a class="yt-timestamp" data-t="00:03:34">[00:03:34]</a>. While previous methods showed that DNA manipulation was possible, they were "bespoke," meaning a unique tool had to be created for every single desired change, making them expensive and time-consuming <a class="yt-timestamp" data-t="00:04:42">[00:04:42]</a>.

CRISPR, rooted in natural processes observed in viruses and bacteria, utilizes proteins directed by RNA molecules (chemical cousins of DNA) to interact with and easily recode DNA sequences <a class="yt-timestamp" data-t="00:05:00">[00:05:00]</a>. This makes CRISPR a programmable tool that can be directed to almost any DNA sequence for precise, controlled changes <a class="yt-timestamp" data-t="00:05:33">[00:05:33]</a>. This transition from slowly, individually changing genes to quick, precise editing is akin to having a text editor for the instruction manual of life <a class="yt-timestamp" data-t="00:05:52">[00:05:52]</a>.

## Core Ethical Divide: Somatic vs. Germline Editing

The power to manipulate DNA sequences has profound implications, ranging from modifying crops to altering heritable traits in human embryos that are passed on for future generations <a class="yt-timestamp" data-t="00:06:11">[00:06:11]</a>. A major divide in the ethical debate centers on whether the editing occurs in somatic cells (non-reproductive cells, where changes end with the individual) or germline cells (where changes are passed down to future descendants) <a class="yt-timestamp" data-t="00:07:13">[00:07:13]</a>.

Germline editing raises significant concerns due to its permanence and the potential to alter the genetic makeup of human populations, echoing historical concepts like eugenics and the cautionary tales of works like Mary Shelley's Frankenstein <a class="yt-timestamp" data-t="00:07:27">[00:07:27]</a>. Embryos cannot consent to these changes, and once made, they are permanent <a class="yt-timestamp" data-t="00:08:00">[00:08:00]</a>.

The discussion also exists on a spectrum:
*   **Treating diseases**: Addressing conditions that are universally agreed upon as diseases <a class="yt-timestamp" data-t="00:08:34">[00:08:34]</a>.
*   **Prevention**: Preventing future diseases <a class="yt-timestamp" data-t="00:08:38">[00:08:38]</a>.
*   **Enhancements**: Moving individuals or their descendants into a new range of what is possible for humans <a class="yt-timestamp" data-t="00:08:42">[00:08:42]</a>.
*   **Super-enhancements**: Moving people beyond current human norms, providing seemingly "superpowers" <a class="yt-timestamp" data-t="00:08:56">[00:08:56]</a>.

## Applications and Their Ethical Considerations

### Curing Single-Gene Diseases (Somatic Editing)

A major success of the CRISPR field is the approval in late 2023 by the US FDA and UK's counterpart of a CRISPR-based therapy for sickle cell disease <a class="yt-timestamp" data-t="00:09:35">[00:09:35]</a>. This "one and done" therapy, exemplified by patient Victoria Gray, suppresses the effect of the disease-causing mutation by turning on the production of fetal hemoglobin, significantly transforming patients' lives <a class="yt-timestamp" data-t="00:10:24">[00:10:24]</a>.

*   **Ethical Perspective**: For severe diseases like sickle cell, hemophilia, Alzheimer's, or Huntington's, it would "almost be unethical not to use it" if safe <a class="yt-timestamp" data-t="00:11:08">[00:11:08]</a>.
*   **Challenges**: The current therapy is expensive, requiring hospitalization and bone marrow transplant <a class="yt-timestamp" data-t="00:11:43">[00:11:43]</a>. It's also best suited for single-gene disorders, while complex diseases like schizophrenia (resulting from hundreds of mutations) are much harder to treat <a class="yt-timestamp" data-t="00:12:17">[00:12:17]</a>. A significant challenge is delivering CRISPR molecules safely and effectively into specific cells or tissues within the body <a class="yt-timestamp" data-t="00:13:08">[00:13:08]</a>. This is analogous to having the ability to cut and paste DNA like a text editor, but still "inventing the postal system" to deliver it <a class="yt-timestamp" data-t="00:16:05">[00:16:05]</a>.

### Preventing Heritable Diseases (Germline Editing)

Huntington's disease, a single-gene neurodegenerative disorder, is a compelling target for CRISPR because it runs in families and currently offers no prevention <a class="yt-timestamp" data-t="00:16:40">[00:16:40]</a>. Theoretically, CRISPR could remove the disease-causing mutation from an embryo, preventing the trait from being passed on to future generations <a class="yt-timestamp" data-t="00:17:37">[00:17:37]</a>.

*   **Ethical Perspective**: If this capability becomes safe, it "would almost be unethical not to use it for that purpose" <a class="yt-timestamp" data-t="00:18:02">[00:18:02]</a>. The argument is that it's difficult to moralize against changing suffering when it can be alleviated <a class="yt-timestamp" data-t="00:22:24">[00:22:24]</a>.
*   **Current Status**: Scientists are "not there yet" due to the complexities of controlling DNA repair in embryos, which remains under investigation <a class="yt-timestamp" data-t="00:18:08">[00:18:08]</a>.

### The He Jiankui Case: A Cautionary Tale

In 2018, a scientist edited human embryos to prevent HIV, resulting in the birth of babies <a class="yt-timestamp" data-t="00:18:45">[00:18:45]</a>. Many scientists, including Jennifer Doudna, opposed this decision <a class="yt-timestamp" data-t="00:18:51">[00:18:51]</a>.

*   **Reasons for Opposition**:
    *   **Risks vs. Benefits**: The risks to the children were greater than the rewards <a class="yt-timestamp" data-t="00:18:56">[00:18:56]</a>. The technology had not been tested in animals prior to human application, a significant ethical concern <a class="yt-timestamp" data-t="00:20:29">[00:20:29]</a>.
    *   **Alternative Treatments**: Well-established, safe treatments already exist to prevent HIV transmission from parent to child <a class="yt-timestamp" data-t="00:20:43">[00:20:43]</a>.
    *   **Unclean Edits**: The genome editing was not "clean," resulting in multiple different kinds of edits and producing "chimeras" (mixtures of different genetic makeups in their cells), with unknown long-term effects <a class="yt-timestamp" data-t="00:21:14">[00:21:14]</a>.
    *   **Informed Consent**: The parents likely did not fully understand the risks <a class="yt-timestamp" data-t="00:20:23">[00:20:23]</a>.

### Preventing Future Diseases / Health Enhancements

This category focuses on preventing diseases before they manifest, such as reducing the risk of Alzheimer's (related to APOE4), heart disease (PCSK9), or cancer (BA) <a class="yt-timestamp" data-t="00:26:02">[00:26:02]</a>. A clinical trial is currently running to use CRISPR as a preventative measure for high cholesterol, targeting the liver <a class="yt-timestamp" data-t="00:26:42">[00:26:42]</a>.

*   **Benefits**: A one-time therapy could free individuals from daily medications and the worry of early heart attacks <a class="yt-timestamp" data-t="00:27:15">[00:27:15]</a>.
*   **Ethical Concerns**: This raises the bar for safety demands, as individuals who are not currently ill would only accept interventions if they significantly improve health without causing harm <a class="yt-timestamp" data-t="00:27:32">[00:27:32]</a>. The "gene gap" concern arises—that access might be limited by wealth, creating societal divisions <a class="yt-timestamp" data-t="00:31:24">[00:31:24]</a>. However, it's argued that expensive technologies often become more accessible over time, and inhibiting development due to early limitations could prevent future widespread benefit <a class="yt-timestamp" data-t="00:31:44">[00:31:44]</a>.

### Enhancements and Super-Enhancements

This involves using gene editing for traits not directly related to disease, such as building larger muscles (MSTN gene), needing less sleep (DEEC2 gene), or increased pain tolerance (gene identified at UC San Francisco) <a class="yt-timestamp" data-t="00:29:21">[00:29:21]</a>.

*   **Ethical Debate**: This is considered a "gray area" where the line between health-related modifications and enhancements becomes blurry, making it difficult to decide who determines what is permissible <a class="yt-timestamp" data-t="00:30:37">[00:30:37]</a>.
*   **Realism**: Most "super-enhancements" like creating super athletes are not yet realistic due to insufficient understanding of how manipulating one gene affects overall health and interconnected genetic systems <a class="yt-timestamp" data-t="00:37:04">[00:37:04]</a>.

### Preimplantation Genetic Diagnosis (PGD) vs. CRISPR

When considering gene editing in embryos, it's done within the context of in vitro fertilization (IVF) <a class="yt-timestamp" data-t="00:33:55">[00:33:55]</a>. IVF allows for [[ethical_debates_surrounding_artificial_reproduction | embryo selection]] through Preimplantation Genetic Diagnosis (PGD), where embryos with certain traits or disease-causing mutations can be identified and avoided <a class="yt-timestamp" data-t="00:34:11">[00:34:11]</a>. The key difference is that PGD merely selects existing embryos, while CRISPR can actively make changes to embryos that might be present in all embryos from a specific couple <a class="yt-timestamp" data-t="00:34:46">[00:34:46]</a>. IVF processes themselves are difficult, time-consuming, and expensive <a class="yt-timestamp" data-t="00:35:05">[00:35:05]</a>.

New developments in human reproduction, such as work on gametes (eggs and sperm), are expected to further change the landscape of what is possible in the coming decades, potentially becoming relevant within the lifetime of today's young children <a class="yt-timestamp" data-t="00:35:30">[00:35:30]</a>.

## Gene Editing Beyond Humans

CRISPR's most immediate and widespread global impact is likely to be seen in plant and animal manipulations <a class="yt-timestamp" data-t="00:38:24">[00:38:24]</a>. While human genetic changes require extensive safety testing, changes in plants can be experimented with more readily and simultaneously <a class="yt-timestamp" data-t="00:38:36">[00:38:36]</a>.

### Plants

CRISPR offers precise manipulation capabilities that were previously unattainable for plant breeders, who traditionally used random changes via chemicals or radiation, which were slow and often led to undesirable side effects <a class="yt-timestamp" data-t="00:39:03">[00:39:03]</a>. With CRISPR, targeted changes can alter only one trait, and it's possible to edit multiple genes (5, 10, or 15) simultaneously for sophisticated alterations <a class="yt-timestamp" data-t="00:40:05">[00:40:05]</a>.

*   **Examples**:
    *   Japan has approved a CRISPR-edited tomato with higher nutritional value <a class="yt-timestamp" data-t="00:41:06">[00:41:06]</a>.
    *   Non-browning mushrooms have been created <a class="yt-timestamp" data-t="00:41:27">[00:41:27]</a>.
    *   Tomatoes with much higher yields that retain taste and appearance have been developed in labs <a class="yt-timestamp" data-t="00:41:34">[00:41:34]</a>.

*   **Regulation**: In the United States, the USDA has ruled that plant DNA changes that could be achieved through traditional breeding (even if accelerated by CRISPR) are not considered genetically modified organisms (GMOs) and are not regulated <a class="yt-timestamp" data-t="00:42:02">[00:42:02]</a>, meaning these crops could soon appear in grocery stores <a class="yt-timestamp" data-t="00:42:32">[00:42:32]</a>.

### Animals and Microbes for Climate and Health

CRISPR can be used to address [[ethical_and_ecological_implications_of_using_genetically_modified_organisms_for_climate_intervention | climate change]] and human health by editing microorganisms.

*   **Climate Intervention**: Scientists are using CRISPR to alter the microbiome (gut bacteria) in cattle to reduce methane production, a powerful greenhouse gas <a class="yt-timestamp" data-t="00:42:52">[00:42:52]</a>. The goal is to develop an easy-to-deploy method, like a pill given once to cows, to sustainably edit their microbiome over their lifetime <a class="yt-timestamp" data-t="00:44:45">[00:44:45]</a>.
*   **Human Health**: The human microbiome profoundly impacts health. CRISPR offers an opportunity to turn down the production of specific molecules by gut microbes that correlate with disease susceptibility, such as preventing asthma in children <a class="yt-timestamp" data-t="00:45:23">[00:45:23]</a>. Further research is exploring the connection between the microbiome and the brain, and the immune system, particularly regarding inflammation and diseases like Alzheimer's <a class="yt-timestamp" data-t="00:46:31">[00:46:31]</a>.

## Conclusion

Few technologies are inherently good or bad; what matters is how they are used <a class="yt-timestamp" data-t="00:52:35">[00:52:35]</a>. With CRISPR, the possibilities, both good and bad, are vast and limited only by imagination <a class="yt-timestamp" data-t="00:52:40">[00:52:40]</a>. The power to control the human species' genetic future is both "awesome and terrifying," and deciding how to handle it may be the biggest challenge humanity has ever faced <a class="yt-timestamp" data-t="00:53:02">[00:53:02]</a>.